Showing 1631-1640 of 8826 results for "".
2018 Therapeutics and Device Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-2018-therapeutics-and-device-highlights/18374/2018 saw new approvals and clearances for acne, impetigo, psoriasis, and skin cancer from Ortho Dermatologics, Sun Pharma, Cutanea, and more. Plus, updates for Restylane, new devices from BTL, Cutera, and others.DermWireTV: USPSTF Tackles Racism; Winlevi Launch; Derm Days in Focus
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-uspstf-tackles-racism-winlevi-launch-derm-days-in-focus/20014/The US Preventive Services Task Force is undertaking efforts to mitigate the influence of systemic racism in its recommendations. Global Psoriasis Day, National Biologics Coordinators Day, and Retinol Day bring attention to skin issues. Sun Pharmaceutical’s Winlevi (clascoterone) cream 1% is now avaOff-label Approaches to Chin Rejuvenation
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/off-label-approaches-to-chin-rejuvenation-/18256/Your Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/practice-management/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/20847/How to Choose the Right Filler
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-to-choose-the-right-filler/19411/Dr. Amy Derick reviews key points about injectable fillers, a non-invasive alternative to surgical facelifts.Galderma FCBCure SoS Hub Chovatiya Video 2
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/galderma-fcbcure-sos-hub-chovatiya-video-2/56736/Raj Chovatiya, MD, PhD, MSCI, FAAD, discusses whether barrier dysfunction drives inflammation and immune dysregulation, or vice versa, or both, in atopic dermatitis.DermwireTV: DermaRite Issues Recall for Several Hand Soaps
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-dermarite-issues-recall-for-several-hand-soaps/37113/In this episode, new research shows switching between interclass biologics may be safe and effective for psoriasis patients; DermaRite recalls 4 skin care products over contamination concerns; and awareness grows for generalized pustular psoriasis through a new global awareness campaign.Your Destination for the Latest Developments in #Dermatology in Print and Online
https://practicaldermatology.com/topics/general-topics/your-destination-for-the-latest-developments-in-dermatology-in-print-and-online/20983/Rafael Nunes, MD on LightSheer Duet and AcuPulse
https://practicaldermatology.com/topics/general-topics/rafael-nunes-md-on-lightsheer-duet-and-acupulse/19284/What Should I Focus On As a Practice Manager?
https://practicaldermatology.com/topics/practice-management/what-should-i-focus-on-as-a-practice-manager/23742/A guide to help you determine items that really need your focus and immediate attention.